Alfred Wittinghofer
SwitzerlandbiochemistMale7.0Global Dominance: 0.00%Alfred Wittinghofer is a biochemist at the Max Planck Institute for Molecular Physiology in Dortmund, Germany. He is renowned for his pioneering work on the structure of RAS proteins, which has laid the foundation for the development of targeted cancer therapies, including the recently introduced Daraxonrasib.
Power618
Reach7,645
Country presence
Recent news mentions
Alfred Wittinghofer is a biochemist at the Max Planck Institute for Molecular Physiology who elucidated the structure of various RAS proteins in the 1980s and 1990s.
Durchbruch mit neuem Medikament DaraxonrasibNeue Zürcher Zeitung·Switzerland· 2026-07-21
Switzerland· 2026-07-21
